Skip to main content
Journal cover image

Combined histopathological risk score using TP53 protein expression, CD8+ T cell density and intratumoral budding is an independent predictor of neoadjuvant therapy response in rectal adenocarcinoma

Publication ,  Journal Article
Chen, W; Farchoukh, L; Seigh, L; Hartman, DJ; Pai, RK
Published in: Histopathology
November 2021

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Histopathology

DOI

EISSN

1365-2559

ISSN

0309-0167

Publication Date

November 2021

Volume

79

Issue

5

Start / End Page

826 / 835

Publisher

Wiley

Related Subject Headings

  • Pathology
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Chen, W., Farchoukh, L., Seigh, L., Hartman, D. J., & Pai, R. K. (2021). Combined histopathological risk score using TP53 protein expression, CD8+ T cell density and intratumoral budding is an independent predictor of neoadjuvant therapy response in rectal adenocarcinoma. Histopathology, 79(5), 826–835. https://doi.org/10.1111/his.14430
Chen, Wei, Lama Farchoukh, Lindsey Seigh, Douglas J. Hartman, and Reetesh K. Pai. “Combined histopathological risk score using TP53 protein expression, CD8+ T cell density and intratumoral budding is an independent predictor of neoadjuvant therapy response in rectal adenocarcinoma.” Histopathology 79, no. 5 (November 2021): 826–35. https://doi.org/10.1111/his.14430.
Journal cover image

Published In

Histopathology

DOI

EISSN

1365-2559

ISSN

0309-0167

Publication Date

November 2021

Volume

79

Issue

5

Start / End Page

826 / 835

Publisher

Wiley

Related Subject Headings

  • Pathology
  • 1103 Clinical Sciences